A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal–gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial

JOURNAL ARTICLE published January 2020 in Therapeutic Advances in Medical Oncology

Authors: Valeria Merz | Camilla Zecchetto | Francesca Simionato | Alessandro Cavaliere | Simona Casalino | Michele Pavarana | Simone Giacopuzzi | Maria Bencivenga | Anna Tomezzoli | Raffaela Santoro | Vita Fedele | Serena Contarelli | Irene Rossi | Serena Giacomazzi | Martina Pasquato | Cristiana Piazzola | Stefano Milleri | Giovanni de Manzoni | Davide Melisi